In this study, the significant transcription factor targets included E2F2 and E2F4, which suggested that CDH23 may play crucial roles in cell progression of DLBCL via interacting with E2F2 and E2F4. This evidence concerns the gene E2F2 and diffuse large B-cell lymphoma.